Clinical Trial Update: A Study of ST-1898 for Unresectable or Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ST-1898 for unresectable or metastatic melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ST-1898

Snippet

Sponsor: Beijing Scitech-Mq Pharmaceuticals Limited | Conditions: Unresectable or Metastatic Melanoma | Phase 1, Phase 2 | Status: RECRUITING